Related Experiment Video
Updated: May 4, 2026

Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models
Published on: November 11, 2020
Component-specific, cigarette particle deposition modeling in the human respiratory tract
Bahman Asgharian1, Owen T Price, Caner U Yurteri
1Department of Security Engineering & Applied Sciences, Applied Research Associates , Raleigh, NC , USA and.
This study developed a particle deposition model for cigarette smoke particles (CSP) to understand lung dose and inform harm reduction strategies. The model accounts for particle growth, shrinkage, and cloud effects, improving predictions of inhaled smoke deposition.
Area of Science:
- Environmental Health Sciences
- Toxicology
- Aerodynamics
Background:
- Inhaled cigarette smoke particles (CSP) cause adverse health effects.
- Understanding localized dose in the lungs is crucial for harm reduction.
Purpose of the Study:
- To develop a specific particle deposition model for CSP in the oral cavity and lungs.
- To account for particle size changes and cloud effects during inhalation.
Main Methods:
- Developed a particle deposition model incorporating hygroscopicity, phase change, coagulation, and nicotine evaporation.
- Included cloud effects on particle drag and deposition.
- Modeled particle losses in the oral cavity during puffing and mouth-hold.
Main Results:
- Cigarette particles grow via hygroscopicity/coagulation and shrink via nicotine evaporation, reaching a stable size.
- Predicted particle deposition was higher when cloud effects were considered.
- Cloud movement explains greater-than-expected particle deposition.
Conclusions:
- The CSP deposition model aids in determining the fate of inhaled smoke in the lungs.
- This knowledge supports health assessments and the identification of harmful CSP components for reduction.
More Related Videos
09:50Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke
Published on: February 12, 2015
09:27Multicellular Human Alveolar Model Composed of Epithelial Cells and Primary Immune Cells for Hazard Assessment
Published on: May 6, 2020